Cargando…

Tumor suppressor DRD2 facilitates M1 macrophages and restricts NF-κB signaling to trigger pyroptosis in breast cancer

Rationale: Breast cancer (BrCa) is the most common cancer worldwide, and the 5-year relative survival rate has declined in patients diagnosed at stage IV. Advanced BrCa is considered as incurable, which still lack effective treatment strategies. Identifying and characterizing new tumor suppression g...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Yiqing, Sun, Ran, Liu, Lei, Yang, Dejuan, Xiang, Qin, Li, Li, Tang, Jun, Qiu, Zhu, Peng, Weiyan, Wang, Yuanyuan, Ye, Lin, Ren, Guosheng, Xiang, Tingxiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039962/
https://www.ncbi.nlm.nih.gov/pubmed/33859743
http://dx.doi.org/10.7150/thno.58322
_version_ 1783677697129447424
author Tan, Yiqing
Sun, Ran
Liu, Lei
Yang, Dejuan
Xiang, Qin
Li, Li
Tang, Jun
Qiu, Zhu
Peng, Weiyan
Wang, Yuanyuan
Ye, Lin
Ren, Guosheng
Xiang, Tingxiu
author_facet Tan, Yiqing
Sun, Ran
Liu, Lei
Yang, Dejuan
Xiang, Qin
Li, Li
Tang, Jun
Qiu, Zhu
Peng, Weiyan
Wang, Yuanyuan
Ye, Lin
Ren, Guosheng
Xiang, Tingxiu
author_sort Tan, Yiqing
collection PubMed
description Rationale: Breast cancer (BrCa) is the most common cancer worldwide, and the 5-year relative survival rate has declined in patients diagnosed at stage IV. Advanced BrCa is considered as incurable, which still lack effective treatment strategies. Identifying and characterizing new tumor suppression genes is important to establish effective prognostic biomarkers or therapeutic targets for late-stage BrCa. Methods: RNA-seq was applied in BrCa tissues and normal breast tissues. Through analyzing differentially expressed genes, DRD2 was selected for further analysis. And expression and promoter methylation status of DRD2 were also determined. DRD2 functions were analyzed by various cell biology assays in vitro. Subcutaneous tumor model was used to explore DRD2 effects in vivo. A co-cultivated system was constructed to investigate interactions of DRD2 and macrophages in vitro. WB, IHC, IF, TUNEL, qRT-PCR, Co-IP, Antibody Array, and Mass Spectrum analysis were further applied to determine the detailed mechanism. Results: In BrCa, DRD2 was found to be downregulated due to promoter methylation. Higher expression of DRD2 positively correlated with longer survival times especially in HER2-positive patients. DRD2 also promoted BrCa cells sensitivity to Paclitaxel. Ectopic expression of DRD2 significantly inhibited BrCa tumorigenesis. DRD2 also induced apoptosis as well as necroptosis in vitro and in vivo. DRD2 restricted NF-κB signaling pathway activation through interacting with β-arrestin2, DDX5 and eEF1A2. Interestingly, DRD2 also regulated microenvironment as it facilitated M1 polarization of macrophages, and triggered GSDME-executed pyroptosis. Conclusion: Collectively, this study novelly manifests the role of DRD2 in suppressing BrCa tumorigenesis, predicting prognosis and treatment response. And this study further reveals the critical role of DRD2 in educating M1 macrophages, restricting NF-κB signaling pathway and triggering different processes of programmed cell death in BrCa. Taking together, those findings represent a predictive and therapeutic target for BrCa.
format Online
Article
Text
id pubmed-8039962
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-80399622021-04-14 Tumor suppressor DRD2 facilitates M1 macrophages and restricts NF-κB signaling to trigger pyroptosis in breast cancer Tan, Yiqing Sun, Ran Liu, Lei Yang, Dejuan Xiang, Qin Li, Li Tang, Jun Qiu, Zhu Peng, Weiyan Wang, Yuanyuan Ye, Lin Ren, Guosheng Xiang, Tingxiu Theranostics Research Paper Rationale: Breast cancer (BrCa) is the most common cancer worldwide, and the 5-year relative survival rate has declined in patients diagnosed at stage IV. Advanced BrCa is considered as incurable, which still lack effective treatment strategies. Identifying and characterizing new tumor suppression genes is important to establish effective prognostic biomarkers or therapeutic targets for late-stage BrCa. Methods: RNA-seq was applied in BrCa tissues and normal breast tissues. Through analyzing differentially expressed genes, DRD2 was selected for further analysis. And expression and promoter methylation status of DRD2 were also determined. DRD2 functions were analyzed by various cell biology assays in vitro. Subcutaneous tumor model was used to explore DRD2 effects in vivo. A co-cultivated system was constructed to investigate interactions of DRD2 and macrophages in vitro. WB, IHC, IF, TUNEL, qRT-PCR, Co-IP, Antibody Array, and Mass Spectrum analysis were further applied to determine the detailed mechanism. Results: In BrCa, DRD2 was found to be downregulated due to promoter methylation. Higher expression of DRD2 positively correlated with longer survival times especially in HER2-positive patients. DRD2 also promoted BrCa cells sensitivity to Paclitaxel. Ectopic expression of DRD2 significantly inhibited BrCa tumorigenesis. DRD2 also induced apoptosis as well as necroptosis in vitro and in vivo. DRD2 restricted NF-κB signaling pathway activation through interacting with β-arrestin2, DDX5 and eEF1A2. Interestingly, DRD2 also regulated microenvironment as it facilitated M1 polarization of macrophages, and triggered GSDME-executed pyroptosis. Conclusion: Collectively, this study novelly manifests the role of DRD2 in suppressing BrCa tumorigenesis, predicting prognosis and treatment response. And this study further reveals the critical role of DRD2 in educating M1 macrophages, restricting NF-κB signaling pathway and triggering different processes of programmed cell death in BrCa. Taking together, those findings represent a predictive and therapeutic target for BrCa. Ivyspring International Publisher 2021-03-05 /pmc/articles/PMC8039962/ /pubmed/33859743 http://dx.doi.org/10.7150/thno.58322 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Tan, Yiqing
Sun, Ran
Liu, Lei
Yang, Dejuan
Xiang, Qin
Li, Li
Tang, Jun
Qiu, Zhu
Peng, Weiyan
Wang, Yuanyuan
Ye, Lin
Ren, Guosheng
Xiang, Tingxiu
Tumor suppressor DRD2 facilitates M1 macrophages and restricts NF-κB signaling to trigger pyroptosis in breast cancer
title Tumor suppressor DRD2 facilitates M1 macrophages and restricts NF-κB signaling to trigger pyroptosis in breast cancer
title_full Tumor suppressor DRD2 facilitates M1 macrophages and restricts NF-κB signaling to trigger pyroptosis in breast cancer
title_fullStr Tumor suppressor DRD2 facilitates M1 macrophages and restricts NF-κB signaling to trigger pyroptosis in breast cancer
title_full_unstemmed Tumor suppressor DRD2 facilitates M1 macrophages and restricts NF-κB signaling to trigger pyroptosis in breast cancer
title_short Tumor suppressor DRD2 facilitates M1 macrophages and restricts NF-κB signaling to trigger pyroptosis in breast cancer
title_sort tumor suppressor drd2 facilitates m1 macrophages and restricts nf-κb signaling to trigger pyroptosis in breast cancer
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039962/
https://www.ncbi.nlm.nih.gov/pubmed/33859743
http://dx.doi.org/10.7150/thno.58322
work_keys_str_mv AT tanyiqing tumorsuppressordrd2facilitatesm1macrophagesandrestrictsnfkbsignalingtotriggerpyroptosisinbreastcancer
AT sunran tumorsuppressordrd2facilitatesm1macrophagesandrestrictsnfkbsignalingtotriggerpyroptosisinbreastcancer
AT liulei tumorsuppressordrd2facilitatesm1macrophagesandrestrictsnfkbsignalingtotriggerpyroptosisinbreastcancer
AT yangdejuan tumorsuppressordrd2facilitatesm1macrophagesandrestrictsnfkbsignalingtotriggerpyroptosisinbreastcancer
AT xiangqin tumorsuppressordrd2facilitatesm1macrophagesandrestrictsnfkbsignalingtotriggerpyroptosisinbreastcancer
AT lili tumorsuppressordrd2facilitatesm1macrophagesandrestrictsnfkbsignalingtotriggerpyroptosisinbreastcancer
AT tangjun tumorsuppressordrd2facilitatesm1macrophagesandrestrictsnfkbsignalingtotriggerpyroptosisinbreastcancer
AT qiuzhu tumorsuppressordrd2facilitatesm1macrophagesandrestrictsnfkbsignalingtotriggerpyroptosisinbreastcancer
AT pengweiyan tumorsuppressordrd2facilitatesm1macrophagesandrestrictsnfkbsignalingtotriggerpyroptosisinbreastcancer
AT wangyuanyuan tumorsuppressordrd2facilitatesm1macrophagesandrestrictsnfkbsignalingtotriggerpyroptosisinbreastcancer
AT yelin tumorsuppressordrd2facilitatesm1macrophagesandrestrictsnfkbsignalingtotriggerpyroptosisinbreastcancer
AT renguosheng tumorsuppressordrd2facilitatesm1macrophagesandrestrictsnfkbsignalingtotriggerpyroptosisinbreastcancer
AT xiangtingxiu tumorsuppressordrd2facilitatesm1macrophagesandrestrictsnfkbsignalingtotriggerpyroptosisinbreastcancer